Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial

Kasper Iversen, Annette S Jensen, Tim V Jensen, Niels G Vejlstrup, Lars Søndergaard, Annette Schophuus Jensen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    164 Citationer (Scopus)

    Abstract

    To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.
    OriginalsprogEngelsk
    TidsskriftEuropean Heart Journal
    Vol/bind31
    Udgave nummer9
    Sider (fra-til)1124-31
    Antal sider8
    ISSN0195-668X
    DOI
    StatusUdgivet - 1 maj 2010

    Citationsformater